Does SPARSENTAN Cause Hepatic function abnormal? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic function abnormal have been filed in association with SPARSENTAN (FILSPARI). This represents 0.3% of all adverse event reports for SPARSENTAN.
9
Reports of Hepatic function abnormal with SPARSENTAN
0.3%
of all SPARSENTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hepatic function abnormal From SPARSENTAN?
Of the 9 reports.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPARSENTAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does SPARSENTAN Cause?
Dizziness (521)
Fatigue (448)
Hypotension (377)
Product use in unapproved indication (262)
Nausea (231)
Peripheral swelling (197)
Headache (186)
Pruritus (171)
Blood creatinine increased (145)
Glomerular filtration rate decreased (141)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which SPARSENTAN Alternatives Have Lower Hepatic function abnormal Risk?
SPARSENTAN vs SPESOLIMAB-SBZO
SPARSENTAN vs SPIRAMYCIN
SPARSENTAN vs SPIRIVA
SPARSENTAN vs SPIRONOLACTONE
SPARSENTAN vs SPRYCEL